Edition:
United States

Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

91.76USD
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
$91.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
430,024
52-wk High
$106.69
52-wk Low
$75.84

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 391.71 -0.071
Jun '18 372.85 -0.095
Mar '18 373.45 -0.277
FY 2017 Dec '17 358.30 -0.052
Sep '17 334.15 -0.072
Jun '17 317.45 -0.211
Mar '17 303.74 -0.094
FY 2016 Dec '16 300.09 -0.457
Sep '16 279.90 -0.223
Jun '16 300.13 -2.577
Mar '16 236.74 -0.514
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 18 379.68 398.00 362.60 410.90
Quarter Ending Mar-19 12 402.43 448.00 381.00 468.11
Year Ending Dec-18 24 1,515.57 1,528.30 1,500.60 1,496.70
Year Ending Dec-19 23 1,734.39 1,791.40 1,661.00 1,763.02
Earnings (per share)
Quarter Ending Dec-18 18 -0.23 -0.05 -0.40 -0.01
Quarter Ending Mar-19 12 -0.08 0.13 -0.26 0.20
Year Ending Dec-18 20 -0.65 -0.43 -0.83 -0.26
Year Ending Dec-19 20 -0.03 0.62 -0.72 0.71
LT Growth Rate (%) 1 47.20 47.20 47.20 25.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.14 29.53
P/E High - Last 5 Yrs. -- 41.51 46.39
P/E Low - Last 5 Yrs. -- 23.69 24.60
Beta 1.62 0.89 0.87
Price to Sales (TTM) 11.13 21.72 22.95
Price to Book (MRQ) 5.71 3.88 4.15
Price to Tangible Book (MRQ) 7.49 14.73 13.93
Price to Cash Flow (TTM) 1,341.64 20.26 20.94
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.74 1.64
Dividend Yield - 5 Year Avg -- 1.52 1.44
Dividend 5 Year Growth Rate -- -8.82 -6.04
Payout Ratio(TTM) -- 45.36 43.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 17.23 4.75 6.93
Sales (TTM) vs TTM 1 Yr. Ago 19.19 4.18 5.64
Sales - 5 Yr. Growth Rate 21.28 6.82 7.40
EPS (MRQ) vs Qtr. 1 Yr. Ago 0.60 35.47 31.31
EPS (TTM) vs TTM 1 Yr. Ago 40.69 -- --
EPS - 5 Yr. Growth Rate -- 6.65 7.72
Capital Spending - 5 Yr. Growth Rate 34.91 7.69 8.04

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.26 2.59 2.57
Current Ratio (MRQ) 2.87 3.56 3.54
LT Debt to Equity (MRQ) 28.34 8.98 11.13
Total Debt to Equity (MRQ) 41.18 13.02 15.47
Interest Coverage (TTM) -10.29 47.18 40.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 78.87 54.86 54.22
Gross Margin - 5 Yr. Avg. 82.21 52.91 52.88
EBITD Margin (TTM) -5.58 -- --
EBITD - 5 Yr. Avg -13.48 18.46 15.99
Operating Margin (TTM) -1.83 11.38 -15.93
Operating Margin - 5 Yr. Avg. -25.80 14.19 11.25
Pre-Tax Margin (TTM) -2.99 12.08 -14.34
Pre-Tax Margin - 5 Yr. Avg. -28.65 14.62 11.56
Net Profit Margin (TTM) -5.83 8.60 -17.68
Net Profit Margin - 5 Yr. Avg. -25.70 10.85 7.82
Effective Tax Rate (TTM) -- 21.56 21.42
Effective Tax Rate - 5 Yr. Avg. -- 23.85 24.42

Efficiency

  Company industry sector
Revenue/Employee (TTM) 579,738 845,823,831 736,529,395
Net Income/Employee (TTM) -33,806 98,036,940 85,218,451
Receivable Turnover (TTM) 4.70 5.23 5.31
Inventory Turnover (TTM) 0.65 2.63 4.11
Asset Turnover (TTM) 0.32 0.89 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -1.88 10.79 10.32
Return on Assets - 5 Yr. Avg. -7.62 11.44 10.91
Return on Investment (TTM) -2.18 13.50 13.00
Return on Investment - 5 Yr. Avg. -8.62 14.72 14.00
Return on Equity (TTM) -3.05 15.26 14.69
Return on Equity - 5 Yr. Avg. -11.93 15.86 15.29
  1 Year 3 Year 5 Year
Sales % 17.62 20.58 21.28
EPS (TTM) % 88.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Biomarin Pharmaceutical Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.78 -8.94 66 83
13 Week -9.33 -5.40 99 93
26 Week 5.43 5.02 99 89
52 Week 15.37 9.55 99 64
YTD 4.88 3.01 99 65
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 667
Total Shares Held: 188,779,779
3 Mo. Net Change: -668,125
# New Positions: 28
# Closed Positions: 23
# Increased Positions: 183
# Reduced Positions: 160
# Net Buyers: 23
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.